Abstract
We had previously identified the mutant allele of apm1+ that encodes a homolog of the mammalian μ 1A subunit of the clathrin-associated adaptor protein-1 (AP-1) complex and demonstrated that the AP-1 complex plays a role in Golgi/endosome trafficking, secretion, and vacuole fusion in fission yeast. Here, we isolated a mutant allele of its4+/sip1+, which encodes a conserved AP-1 accessory protein. The its4-1/sip1-i4 mutants and apm1 -deletion cells exhibited similar phenotypes, including sensitivity to the calcineurin inhibitor FK506, Cl− and valproic acid as well as various defects in Golgi/endosomal trafficking and cytokinesis. Electron micrographs of sip1-i4 mutants revealed vacuole fragmentation and accumulation of abnormal Golgi-like structures and secretory vesicles. Overexpression of Apm1 suppressed defective membrane trafficking in sip1-i4 mutants. The Sip1-green fluorescent protein (GFP) co-localized with Apm1-mCherry at Golgi/endosomes, and Sip1 physically interacted with each subunit of the AP-1 complex. We found that Sip1 was a Golgi/endosomal protein and the sip1-i4 mutation affected AP-1 localization at Golgi/endosomes, thus indicating that Sip1 recruited the AP-1 complex to endosomal membranes by physically interacting with each subunit of this complex. Furthermore, Sip1 is required for the correct localization of Bgs1/Cps1, 1,3-β-D-glucan synthase to polarized growth sites. Consistently, the sip1-i4 mutants displayed a severe sensitivity to micafungin, a potent inhibitor of 1,3-β-D-glucan synthase. Taken together, our findings reveal a role for Sip1 in the regulation of Golgi/endosome trafficking in coordination with the AP-1 complex, and identified Bgs1, required for cell wall synthesis, as the new cargo of AP-1-dependent trafficking.
Introduction
Clathrin adaptor protein (AP) complexes play a key role in the transport of proteins by regulating the formation of transport vesicles as well as cargo selection between organelles of the post-Golgi network, namely the trans-Golgi network, endosomes, lysosomes, and the plasma membrane [1]. Four basic AP complexes (AP-1, AP-2, AP-3, and AP-4) have been described, and all four complexes are heterotetramers comprising the two large subunits γ/α/δ/σ and β1/β2/β3/β4, a medium-sized or μ subunit, and a small or σ subunit [2], [3]. AP-1, AP-2, and AP-3 are encoded in all eukaryotic cells examined until date, whereas AP-4 is not found in the fruit fly, nematode, and the yeasts.
Recently, accessory proteins that bind to the AP complex have been attracting increasing attention for their role in membrane trafficking as well as in signaling pathways [4], [5]. Compared with AP-2-binding proteins, less is known about AP-1 accessories with the exceptions of γ-synergin [6], Eps15 [7], epsinR [8], and p200 [9]. γ-Synergin is associated with AP-1 both in the cytosol and on trans-Golgi network (TGN) membranes. It binds directly to the ear domain of γ-adaptin and contains an Eps15 homology (EH) domain, although the EH domain is not part of the γ-adaptin binding site.
Eps15 (EGFR pathway substrate clone 15) was first identified as a substrate for EGF receptor tyrosine kinase [10], [11]. Eps15 is well known for its role in clathrin-coated vesicle formation in the plasma membrane through interactions with other clathrin adaptor proteins such as AP-2. In addition to its localization in the plasma membrane, Eps15 is found in the TGN in association with TGN clathrin adaptor AP-1, mediating the formation of Golgi-derived vesicles [12].
EpsinR is a highly conserved clathrin-coated vesicle enriched protein that binds to phosphatidylinositol-4-phosphate, clathrin, and the gamma appendage domain of AP-1 [13]. EpsinR plays a role in AP-1/clathrin budding events in the cell. Another AP-1-interacting protein, aftiphilin, was identified after searching databases for sequences that contained the γ-ear-binding motif [13], [14]. Aftiphilin co-elutes with two other AP-1 binding partners, p200a and γ-synergin. In general, the aftiphilin/p200/γ-synergin complex has been reported to facilitate AP-1 functions although this complex may have additional functions [15].
In a search for mutants sensitive to the immunosuppressive drug FK506, we previously identified a mutant allele of the apm1 + gene that encodes a μ1 subunit of the AP-1 complex and characterized the role of Apm1 in Golgi/endosome trafficking, vacuole fusion, and secretion in fission yeast [16]. In this organism, the AP-1 complex comprises [Apl2 (β), Apl4 (γ), Apm1 (μ), and Aps1 (σ)] subunits that are all localized to endosomes and are essential for heterotetrameric complex formation [17]. A recent study on budding yeast reported an evolutionarily conserved accessory protein, Laa1p (YJL207C) [18], which shares a significant amino acid similarity with human p200, one of the AP-1 accessory proteins [15]. Laa1 interacted with the clathrin-associated adapter complex AP-1 and was important for the correct localization of the AP-1 complex in Golgi/endosomes, establishing the evolutionary conservation of the function of this protein in AP-1 mediated endosomal trafficking [18]. In 2009, Jourdain et al reported a fission yeast member of the p200/Laa1 family, Sip1, as an essential protein that interacted with the F-box protein Pof6, and concluded that Sip1 was an endocytic vesicle protein important for endocytosis [19]. However, the role of Sip1 as an AP-1 accessory in AP-1 mediated endosomal trafficking, and its functional interactions with other signaling pathways in fission yeast remain undetermined.
In this study, we identified a novel mutant allele of the sip1+ gene, sip1-i4, which was an immunosuppressant- and temperature-sensitive mutant. We demonstrated that Sip1 played an important role in Golgi/endosomal trafficking, but not in endocytosis, and that Sip1 recruited the AP-1 complex to endosomal membranes by physically interacting with this AP-1 complex. Further, we identified Bgs1, required for cell wall synthesis, as the new cargo of AP-1-dependent trafficking.
Materials and Methods
Strains, Media, Genetic and Molecular Biology Methods
The Schizosaccharomyces pombe strains used in this study are listed in Table 1. The complete and minimal media used were yeast extract-peptone-dextrose (YPD) and Edinburgh minimal medium (EMM), respectively [20]. Standard genetic and recombinant DNA methods [21] were used except where stated otherwise. FK506 was provided by Astellas Pharma Inc. (Tokyo, Japan). Genome DNA clones were provided by the National Bio Resource Project, Yeast Genetic Resource Center (Graduate School of Science, Osaka City University).
Table 1. Schizosaccharomyces pombe strains used in this study.
Strain | Genotype | Reference |
HM123 | h − leu1-32 | Our stock |
KP456 | h − leu1-32 ura4-D18 | Our stock |
SP733 | h − leu1-32 sip1-i4 | This study |
KP630 | h − leu1-32 ura4-D18 apm1::ura4+ | Kita et al., (2004) |
SP736 | h − leu1-32 ura4-D18 sip1-i4 | This study |
KP1754 | h − leu1-32 ura4-D18 nmt1 GST-sip1+::KanMx6 | Our stock |
KP1915 | h − leu1-32 ura4-D18 GFP-sip1+::KanMx6 | Our stock |
SP1041 | h − leu1-32 ura4-D18 GFP-sip1+::KanMx6 apm1::ura4+ | This study |
SP1276 | h − leu1-32 ura4-D18 GFP-sip1+::KanMx6 apl2::ura4+ | This study |
SP1278 | h − leu1-32 ura4-D18 GFP-sip1+::KanMx6 apl4::ura4+ | This study |
SP1294 | h − leu1-32 ura4-D18 GFP-sip1+::KanMx6 aps1::ura4+ | This study |
KP1807 | h − leu1-32 ura4-294 nmt1 GFP-sip1+::ura4+ | Our stock |
SP1555 | h − leu1-32 ura4-D18 nmt1 GFP-sip1+::ura4+ sip1-i4 | This study |
SP1428 | h − leu1-32 sip1-62-HA-Kan | This study |
SP1931 | h − leu1-32 sip1-i4 Pbgs1+::GFP-bgs1+::leu1+ | This study |
SP1941 | h − leu1-32 Pbgs1+::GFP-bgs1+::leu1+ | This study |
SP1980 | h − leu1-32 ura4-D18 apm1::ura4+ Pbgs1+::GFP-bgs1+::leu1+ | This study |
KP427 | h − leu1-32 ura4-D18 apl2::ura4+ | Y. Ma et al., (2009) |
SP132 | h − leu1-32 ura4-D18 apl4::ura4+ | This study |
KP3391 | h − leu1-32 ura4-D18 aps1::ura4+ | Y Ma et al., (2009) |
SP1730 | h − leu1-32 ura4-D18 GFP-sip1+::KanMx6 anp1+-linker-mCherry::ura4+ | This study |
SP1732 | h − leu1-32 ura4-D18 nmt1 GFP-sip1+::ura4+ anp1+-linker-mCherry::ura4+ | This study |
SP1966 | h − or + leu1-32 ura4-D18 GFP-sip1+::KanMx6 sec72+-mCherry::ura4+ | This study |
SP1973 | h − or + leu1-32 ura4-D18 nmt1 GFP-sip1+::ura4+ sec72+-mCherry::ura4+ | This study |
SP1964 | h − or + leu1-32 ura4-D18 GFP-sip1+::KanMx6 vrg4+-mCherry::ura4+ | This study |
SP1965 | h − or + leu1-32 ura4-D18 nmt1 GFP-sip1+::ura4+ vrg4+-mCherry::ura4+ | This study |
SP2077 | h − leu1-32 ura4-D18 GFP-sip1+::KanMx6 anp1+-linker-mCherry::ura4+ apm1::ura4+ | This study |
SP2078 | h − or + leu1-32 ura4-D18 GFP-sip1+::KanMx6 vrg4+-mCherry::ura4+ apm1::ura4+ | This study |
SP2079 | h − or + leu1-32 ura4-D18 GFP-sip1+::KanMx6 sec72+-mCherry::ura4+ apm1::ura4+ | This study |
Isolation of its4-1/sip1-i4 Mutants
The its4-1 mutant was isolated during a screen of cells that had been mutagenized with nitrosoguanidine. Strain HM123 cells were mutagenized with 300 µm nitrosoguanidine (Sigma) for 60 min (approximately 10% survival), as described by Moreno et al. Mutants were spread on YPD plates to product approximately 1,000 cells/plate and incubated at 27°C for 4 days. The plates were then replica plated at 36°C to plates containing 0.5 µg/ml FK506. Mutants that showed both FK506 sensitivity and temperature sensitivity were selected. The original mutants that were isolated were back-crossed three times to wild-type strains HM123 and HM528.
Cloning of the sip1+ Gene and Construction of Tagged Its4 Strains
To clone its4+ gene, its4-1 mutant (SP733) was transformed using an S. pombe genomic DNA library constructed in the vector pDB248 [22]. Leu+ transformants were replica-plated onto YPD plates at 36°C, and plasmid DNA was recovered from transformants that exhibited plasmid-dependent rescue. Plasmids that complemented the temperature sensitivity of the its4-1 mutant were cloned and sequenced. Suppressing plasmids contained sip1+ (SPBC27B12.08). The sip1 + gene complemented the immunosuppressant sensitivity and sensitivity to various drugs such as FK506, micafungin, and valproic acid as well as all defects in membrane trafficking such as secretion defects and Golgi/endosomal trafficking defects as evidenced by mislocalization of Syb1 and Vrg4, and vacuole fragmentation associated with its4-1 mutant cells.
For the ectopic expression of proteins, we used the thiamine-repressible nmt1 promoter [23]. Expression was repressed by the addition of 4 µM thiamine to EMM. The carboxy- and amino-terminal epitope-tagged proteins were generated via chromosomal integration of polymerase chain reaction (PCR)-amplified fragments [24]. The C-terminally tagged Its4 strain used in this study behaved like non-tagged parental strains with regard to temperature-sensitivity, immunosuppressant-sensitivity, and sensitivity to drugs including micafungin, indicating that tagging does not interfere with protein function (Figure S1).
Microscopy and Miscellaneous Methods
Light microscopy methods (e.g., fluorescence microscopy) were performed as described previously [16]. Furthermore, FM4-64 labeling, localization of GFP-Syb1, measurement of acid phosphatase secretion, and conventional electron microscopy were performed as described previously [16].
Image Quantification
All the image quantifications were done for 3 individual datasets which summed up to 150 counted cells.
Staining of Vacuoles with Lucifer Yellow
The staining with Lucifer yellow is described in [16]. Briefly, cells were grown to an exponential phase in YES medium, harvested with centrifugation for 3 min at 4°C, resuspended in fresh YES medium containing 5 mg/ml Lucifer yellow carbonyl hydrazine (Sigma-Aldrich), and incubated at 27°C for various periods in time-course experiments. Aliquots were harvested at times indicated, washed three times with the medium, and fluid-phase endocytosis was microscopically observed under the fluorescence microscope.
Results
Isolation of the its4-1/sip1-i4 Mutant
To isolate new molecules that function in membrane trafficking, we searched for mutants sensitive to the immunosuppressive drug FK506 and isolated the its4-1 mutant. As shown in Figure 1A, its4-1 mutants grew equally well compared with the wild-type cells at the permissive temperature of 27°C. However, its4-1 mutant cells failed to grow at either the restrictive temperature of 36°C or, in media containing either 0.3 M MgCl2 or FK506, a specific inhibitor of calcineurin phosphatase, whereas the wild-type cells grew well (Figure 1A, sip1-i4+vector). The its4-1 mutants also showed greater sensitivity to the cell wall-damaging agent micafungin and to valproic acid than did wild-type cells (Figure 1A, sip1-i4+vector).
The its4-1 is an Allele of the sip1+ Gene Encoding Homolog of the Clathrin-associated Adaptor Protein-1 (AP-1) Complex-Interacting Protein
The its4 + gene was cloned by complementation of the temperature-sensitive growth defect of its4-1 mutant cells (Figure 1A, sip1-i4+its4 +). its4 + also complemented sensitivities to drugs associated with the its4-1 mutant (Figure 1A).
Nucleotide sequencing of the cloned DNA fragment revealed that the its4 + gene was identical to the sip1 + gene (SPBC27B12.08), that encodes a 1919 amino acid protein, which shares amino acid similarities with Homo sapien HEATR5B (309/1919, 16.1% identity) and S. cerevisiae Laa1 (329/1919, 17.1% identity). Linkage analysis was performed (see Materials and Methods); it indicated allelism between the sip1 + gene and the its4-1 mutation. We therefore renamed its4-1 as sip1-i4.
To characterize the mutation site in the sip1-i4 allele, genomic DNA from the sip1-i4 mutant was isolated, and the full-length coding region of the sip1-i4 was sequenced. The G-to-A nucleotide substitution caused a serine to be altered to a termination codon at the amino acid position 1434, resulting in a truncated protein product lacking 485 amino acids downstream of the mutation (Figure 1B).
As Jourdain et al. identified the sip1-62 mutant, an independent allele of the sip1+ gene [19], it is intriguing to investigate the phenotypic differences between the two sip1 mutant alleles. As shown in Figure 2A, both sip1-62 and sip1-i4 mutant cells exhibited sensitivities to temperature, valproic acid, micafungin, and the immunosuppressive drug FK506, although the sip1-i4 mutant cells exhibited more pronounced sensitivity to the stresses examined (Figure 2A).
In addition, we examined the effect of the sip1-i4 mutation on cytokinesis, as sip1-62 mutants were reported to show defects in cytokinesis [19]. For this, we monitored the septation index of the two sip1 mutants at the permissive and the restrictive temperatures. The sip1-i4 mutant cells showed a significantly higher septation index than the wild-type and the sip1-62 mutant cells, indicating that both sip1 mutant cells had defects in cytokinesis (Figure 2B, 2C). Notably, FK506 treatment for 1 hr induced the appearance of multi-septated phenotypes in sip1-i4 cells, but not in sip1-62 cells (Figure 2B, arrowheads, Figure 2C). Thus, the effect of FK506 treatment on cytokinesis was more pronounced in sip1-i4 cells than in sip1-62 cells (Figure 2B, 2C). This may be consistent with the finding that sip1-i4 cells exhibited more pronounced sensitivity to FK506 than did sip1-62 cells at 27°C.
Electron Microscopic Analysis of sip1-i4 Cells
Sip1 was previously identified as a novel F-box protein interactor essential for cytokinesis and endocytosis [19]. In order to gain a detailed insight into the role of Sip1 in membrane trafficking, we analyzed sip1-i4 cells with electron microscopy. In general, electron microscopic analysis of mutants that exhibit defects in membrane trafficking reveals the accumulation of organelles or vesicular intermediates of the compartments that precede the step in which they first function [25], [26], [27]. Wild-type and sip1-i4 cells were cultured at 27°C and examined by electron microscopy in order to determine whether sip1-i4 cells accumulate such organelles or vesicular structures (Figure 3A and 3B). Notably, Golgi structures in sip1-i4 cells were thick, swollen, and frequently multi-lamellar (Figure 3B, B’ and B’’). Moreover, large vesicular structures (diameter, >100 nm) associated with Golgi stacks were observed in sip1-i4 cells (Figure 3B, B’’), suggesting that Sip1 is involved in vesicle formation at the trans-Golgi network. These structures were rarely found in wild-type cells (Figure 3A, wt). Moreover, sip1-i4 cells accumulated putative large post-Golgi vesicles ranging from 100 to 150 nm in size that were intensely stained after permanganate fixation (Figure 3B, B’’’, B’’’’, and 3E); on the other hand, the number of vesicles observed in wild-type cells was extremely low (Figure 3A and 3E). Another striking feature of sip1-i4 cells is that their vacuoles were fragmented (Figure 3A, and 3C, C’, C’’) as compared with those of wild-type cells (Figure 3A, wt). Consistently, sip1-i4 cells exhibited vacuolar fusion defects induced by osmotic stress, in a similar fashion to Δapm1 cells. Hypotonic stress causes a dramatic fusion of vacuoles in wild-type, but not in sip1-i4 or Δapm1 cells (Figure 3D), indicating that Sip1 is required for vacuole fusion. Quantification of the percentages of cells with fragmented vacuoles indicated that more than 90% of the sip1-i4 (98.0% ±2.0%) and Δapm1 (94.0% ±4.0%) cells had fragmented vacuoles, whereas less than 5% of the wild-type cells (2.7% ±1.2%) had fragmented vacuoles (Figure 3D).
Consistent with the accumulation of putative large post-Golgi vesicles, sip1-i4 cells, similar to Δapm1 cells, showed defects in acid phosphatase secretion (Figure 3F). In addition, LAA1 overexpression suppressed these secretion defects in sip1-i4 cells, suggesting that Sip1 shared a functional homology with Laa1 (Figure 3F, sip1-i4+LAA1). It should be noted that abnormal findings seen in the electron micrographs of sip1-i4 cells are similar to the previously reported findings in the ypt3-i5 mutant [27] and Δapm1 cells [16]. This suggested that the role of Sip1 in membrane trafficking was associated with Golgi/endosomes and vacuoles.
sip1 Mutant Cells Exhibit Defects in Golgi/Endosomal Trafficking
The aforementioned results strongly suggested that defects in the membrane trafficking in sip1-i4 and Δapm1 cells were closely related. Thus, we examined the phenotypes of sip1-i4 cells in greater detail and compared these phenotypes with those of the sip1-62 cells identified by Jourdain et al [19]. First, we visualized Syb1 as a GFP-fusion protein in these cells. Syb1, the synaptobrevin in fission yeast, is a vesicle-associated membrane protein that can be copurified with secretory vesicles [28]. In order to assess the Golgi-to-endosome or Golgi-to-plasma membrane trafficking pathway, the localization of GFP-Syb1 was monitored.
As shown in Figure 4A, GFP-Syb1 fluorescence observed in the cytoplasm of wild-type cells was detected as a small punctuate pattern and was co-localized with FM4-64 dots at an early stage of endocytosis (arrowhead, wt); this fluorescence pattern was also enriched in the cell ends and the medial region (arrows, wt). In contrast, GFP-Syb1 did not localize at the cell surface and the cell ends of sip1-i4, sip1-62 and Δapm1 cells (Figure 4A, 4B). Instead, GFP-Syb1 fluorescence was observed as large dot-like structures that co-localized with FM4-64 in Δapm1 cells (Figure 4A, arrowheads, 4C) and partly co-localized with FM4-64 in sip1-i4 and sip1-62 cells (Figure 4A, double arrowheads, 4C). This suggested that, as with Apm1, Sip1 was involved in the Golgi/endosome membrane trafficking pathway. Quantification of Syb1 localization in the cell ends and Syb1 co-localization with FM4-64 confirmed these results (Figure 4B, 4C).
To further characterize the defects in membrane trafficking associated with the Golgi/endosome system in sip1 mutant cells, we investigated the co-localization of the Golgi marker protein Vrg4 [29] and FM4-64. In wild-type cells, GFP-Vrg4 mostly co-localized with FM4-64 (Figure 4D, wt, arrowheads). However, a small number of the Vrg4 positive dots did not co-localize with FM4-64 (Figure 4D, wt, arrow). In contrast, in sip1-i4 and sip1-62 cells, the punctuate fluorescence pattern of Vrg4 did not co-localize with FM4-64 (Figure 4D). Quantification of Vrg4 co-localization with FM4-64 showed that 8.0±0.2 of the Vrg4 punctates co-localized with FM4-64 fluorescence in wild-type cells, whereas 0.2±0.1, and 0.2±0.1 of the Vrg4 punctates co-localized with FM4-64 in sip1-i4 and sip1-62 cells, respectively (Figure 4E).
In budding yeast, the GDP mannose transporter predominantly localizes to the Golgi apparatus as detected by indirect immunofluorescent staining [30]. Abe et al. also investigated the mechanism of Golgi-resident Vrg4 protein in the stream of vesicular traffic, and found that Vrg4p is recycling between the ER and Golgi apparatus [31]. In S. pombe, our previous paper showed that Vrg4 mostly co-localized with the Golgi marker Krp1, which suggested that Vrg4 was predominantly localized to the Golgi, similar to what is observed in budding yeast [17]. Thus, we hypothesize that the Vrg4-positive dots that co-localize with FM4-64 may represent Golgi, and that the Vrg4-positive dots that did not co-localize with FM4-64 may represent unidentified structures, including the ER. Altogether, these results indicated that both sip1 mutant alleles resulted in defects in Golgi/endosomal membrane trafficking.
Sip1 is not Essential for Endocytosis
To determine if the endocytosis defects reported by Jourdain et al. were specific to the sip1-62 mutant allele, we performed a time-course experiment using FM4-64, a vital dye that is internalized in living cells through endocytosis and accumulates in vacuoles [32]. As a control, we used Δapm1 cells in which endocytosis was not impaired [16]. In wild-type cells, small fluorescent dots appeared in the cytoplasm within 5 min of incubation at 27°C (Figure 5A, 5 min, wt); these dots became increasingly brighter over the next 10 min (Figure 5A, 15 min, wt). The staining of these endosomal intermediates subsequently decreased concomitant with the appearance of FM4-64 in vacuolar membranes (Figure 5A, 30 min, wt, arrows). After 60 min, FM4-64 staining was predominant in the vacuoles (Figure 5A, 60 min, wt, arrows).
In sip1-i4, sip1-62 and Δapm1 cells, FM4-64-labeled endosomal intermediates had kinetics similar to that observed in wild-type cells, indicating that the internalization step of endocytosis was not impaired in these mutants (Figure 5A, 5 min, 15 min, 30 min). Subsequent delivery to the vacuole was not impaired in these mutant cells, although some FM4-64 fluorescent dots were observed in most of the sip1-i4 mutant (98.01% ±2.01%) and the sip1-62 mutant cells (85.31% ±4.21%). By comparison, the appearance of these dots was less frequent in wild-type cells (16.01% ±2.01%) and Δapm1 cells (38.71% ±3.1%). This suggested that there were defects in post-endocytic endosomal trafficking toward the vacuole in sip1 mutants (Figure 5A, 60 min, arrowheads). Because the vacuoles in sip1 and Δapm1 mutants were smaller and highly fragmented (Figure 5A, 60 min, arrows), it could not be definitely concluded that the dye had reached up to the vacuoles or the late endosomes.
Therefore, we performed another time-course experiment using the membrane-impermeable fluorescence dye Lucifer yellow to monitor the fluid phase of endocytosis [33]. After 30 min incubation, the vacuoles in wild-type, sip1-i4, sip1-62 and Δapm1 cells were observed as fluorescence-positive compartments (Figure 5B, 30 min, arrows), and there was no significant delay in dye uptake over the time course in these mutant cells. In contrast, Lucifer yellow uptake was not observed in the endocytosis-defective mutant, as was the case for a ypt7 disruption strain [34] (our unpublished data). Therefore, we concluded that Sip1 was not essential for endocytosis but it was involved in post-endocytic endosomal trafficking towards the vacuole.
Sip1 Shows Genetic Interactions with Apm1
To investigate the functional relationship between Sip1 and Apm1, we investigated the effect of Apm1 overexpression on the membrane-trafficking defects in sip1-i4 cells. We first examined the effect of Apm1 overexpression on abnormal localization of GFP-fused Syb1 in sip1-i4 cells. GFP-Syb1 failed to localize on the cell surface (Figure 6A, sip1-i4+ vector, arrows, 6B, 1.3% ±1.2%), or Golgi/endosomes in sip1-i4 cells; instead, they were observed as large, brightly fluorescent dots in the cytoplasm at 27°C (Figure 6A, sip1-i4+vector, double arrowheads, 6C). Notably, GFP-Syb1 was visible at the cell ends in sip1-i4 cells that harbored apm1 + (Figure 6A, sip1-i4+ apm1 +, arrows, 6B, 50.0% ±7.2%), and Apm1 overexpression recovered normal Syb1 dots that co-localized with FM4-64 (Figure 6A, sip1-i4+ apm1 +, arrowheads, 6C, 6.4±0.4).
Next, we examined the effect of Apm1 overexpression on vacuole fusion observed in sip1-i4 cells (Figure 3C). After the cells were labeled with FM4-64 for 60 min, collected, washed, and resuspended in water for 90 min, the wild-type cells had large prominent vacuoles resulting from vacuole fusion (Figure 6D, wt + vector, 2.7% ±1.2%). On the other hand, vacuoles in the sip1-i4 cells remained small and numerous (Figure 6D, sip1-i4+ vector, 98.0% ±7.2%), indicating a defect in vacuole fusion. In contrast, the sip1-i4 cells transformed with apm1+ contained larger vacuoles compared with those harboring the vector alone, indicating that Apm1 overexpression partially, but clearly, suppressed the defects in vacuole fusion observed in sip1-i4 cells (Figure 6D, sip1-i4+ apm1 +, 14.7% ±4.2%). We further examined the effect of apm1+ overexpression on the secretion defects in associated with sip1-i4 cells. Overexpression of apm1+ partially, but significantly, stimulated secretion in sip1-i4 cells (Figure 6E, sip1-i4+ apm1 +).
Sip1 Associates with the AP-1 Complex in S. pombe
Next, we examined whether Sip1 could bind to each subunit of the AP-1 complex. To this end, we fused Sip1 to glutathione-S-transferase (GST) and overexpressed the fusion protein using an inducible nmt1 promoter; the induced cells were used to prepare lysates. These lysates were then used in binding experiments in which purified full-length Apm1, Apl2, Apl4, and Aps1 were fused to GFP or to the control GFP protein. Results showed that the Sip1 protein bound to each of the subunits of the AP-1 complex (Figure 7A). Thus, Sip1, like Laa1 in budding yeast [18] and the mammalian homologue p200 [9], acts as an AP-1 complex-interacting protein.
Sip1 is an Endosomal Protein
Next, we examined localization of Sip1. Experiments were performed with Sip1-tagged with GFP expressed chromosomally under its own promoter, and GFP-tagging at its C-terminus did not affect Sip1-GFP function, which was indicated by the findings that C-terminally tagged Sip1-GFP strain showed no sensitivity to high temperature, or various drugs, including FK506 and micafungin (Figure S1A). Sip1-GFP was localized in the dot-like structures observed in the cytoplasm (Figure 7B, arrowheads), which co-localized with FM4-64 during an early stage of endocytosis. After 5 min of dye uptake, most Sip1-GFP dot-like structures were co-localized with FM4-64-positive structures (Figure 7B, Sip1-GFP, arrowheads). In addition, we constructed a strain in which Sip1 was chromosomally tagged with GFP at its N-terminus and expressed under the nmt1 promoter. In this strain, as reported by Jourdain et al., Sip1 localizes in the nucleus in addition to the dots, which co-localized with FM4-64 during an early stage of endocytosis (Figure 7B, GFP-Sip1, arrowheads) [19]. It should be noted that the differences in the localization of the Sip1 protein in the nucleus plus the Golgi/endosomes may be attributable to the utilization of an inducible nmt1 promoter and/or differences in tagging of the Sip1 protein wherein GFP was fused to its N-terminus or C-terminus. To allow co-localization with Sip1-GFP, we tagged Apm1 with the fluorescent epitope mCherry and the resultant Apm1-mCherry protein expressed from its endogenous promoter was detectable at the dot-like structures and the nucleus, similar to the findings reported with endogenous Apm1 protein tagged with GFP [16]. When Sip1-GFP and Apm1-mCherry were co-expressed in wild-type cells from their own promoters, some of the punctuate structures of Sip1 co-localized with Apm1 dots in the cytoplasm (Figure 7C; upper panel, arrowheads). Furthermore, we confirmed the co-localization between Sip1 and Apm1 dots in the cytoplasm using nmt1-GFP-Sip1 protein (Figure 7C; lower panel, arrowheads). We also evaluated the co-localization of Sip1 with mCherry-tagged Anp1 and Sec72, which are cis-Golgi and trans-Golgi marker proteins, respectively. Sip1-GFP or GFP-Sip1 did not co-localize with Anp1-mCherry (Figure S1B), and both proteins partially co-localized with Sec72-mCherry (Figure S1C). Together, these results indicated that Sip1 was an endosomal protein, but not an endocytic vesicle protein.
The AP-1 Complex is Mislocalized in sip1-i4 Mutant Cell
We next examined the effect of sip1-i4 mutation on the intracellular localization of the individual subunit of the AP-1 complex, namely Aps1, Apl2, Apm1 and Apl4. As shown in Figure 8, the dot-like fluorescence of Apm1-GFP, GFP-Apl2, Aps1-GFP and GFP-Apl4 co-localized with FM4-64-positive structures in wild-type cells, suggesting that the four adaptin subunits of the AP-1 complex are localized to the Golgi/endosomes. In contrast, in sip1-i4 mutant cells, Apm1, Apl2, and Aps1 failed to localize to the Golgi/endosomes (Figure 8), as the specific dot-like structures were hardly observed in sip1-i4 mutant cells. Instead, they localized diffusely in the cytoplasm and were enriched in the nucleus. GFP-Apl4 was observed as numerous punctuate structures in sip1-i4 mutant cells, but not in the nucleus, although these dot-like structures rarely co-localized with FM4-64; this was in contrast to the situation in the wild-type cells in which most Apl4 dots merged with FM4-64 (Figure 8D, arrowheads). These results suggest that the sip1-i4 mutation affected the localization of AP-1 complex to the Golgi/endosomes. In a reciprocal experiment, Sip1-GFP was examined in wild-type and the deletion strain of each of the adaptin subunits. Sip1-GFP distribution seemed to be unaltered in either of these deletion mutant cells wherein dot-like structures of Sip1 co-localized with FM4-64. We then tried to determine the localization of Sip1-GFP in Δapm1 cells by examining the co-localization of Sip1-GFP with the cis-Golgi marker Anp1, and the trans-Golgi marker Sec72 and compared these localizations with those in wild-type cells. These results showed that Sip1-GFP partly co-localized with Sec72, but not with Anp1 in Δapm1 cells, which suggested that Sip1-GFP was partly localized in the trans-Golgi apparatus and partly localized in endosomes in Δapm1 cells. These localization patterns were similar to those obtained with the wild-type cells indicating that the AP-1 complex was not required for the localization of Sip1 to Golgi/endosomes (Figure S2).
Sip1/AP-1 is Required for Transporting Glucan Synthase Bgs1 from Golgi/Endosomes to the Plasma Membrane
What is the mechanism of the FK506 sensitivity observed in sip1-i4 cells? One possibility is that calcineurin regulates the enzymes involved in cell wall synthesis and/or their breakdown, thereby affecting cell wall integrity. If Sip1/AP-1 is involved in the proper transport/function of cell wall biosynthesis enzymes, the combined defects in the Sip1/AP-1 system and calcineurin may result in lethality. One attractive candidate cargo of AP-1 dependent trafficking is Bgs1/Cps1, because Bgs1 is an enzyme involved in beta 1, 3-glucan synthesis and, therefore, is important for cell wall integrity [35], [36]. In addition, our previous screen identified bgs1-i2, a mutant allele of the bgs1 + gene, which exhibited temperature- and immunosuppressant sensitivity [37]. Thus, we examined the effects of the loss of Sip1/AP-1 system function on the localization of Bgs1, by visualizing GFP-Bgs1 expressed chromosomally under its own promoter.
In wild-type cells, Bgs1 was localized to the growing ends at 27°C (Figure 9A, wt, arrows), consistent with a previous report [38]. Notably, the dot-like fluorescence pattern of GFP-Bgs1 was also observed in the cytoplasm of wild-type cells. These Bgs1 dots co-localized with FM4-64 in the early stage of endocytosis (Figure 9A, wt, arrowheads), which indicated that Bgs1 was localized to Golgi/endosomes. In contrast, in sip1-i4 cells, the localization of Bgs1 to the cell ends was impaired, which was also supported by the quantification of Bgs1 localization to the cell ends (Figure 9A, 9B, sip1-i4). In addition, Bgs1 was observed as a large cluster in the cytoplasm (Figure 9A, sip1-i4, arrowheads) and the number of Bgs1 dots that co-localized with FM4-64 was significantly lower in sip1-i4 cells (0.6±0.1) as compared with the wild-type cells (5.2±0.2; Figure 9C). In Apm1 deletion cells, the localization of Bgs1 was similar to that observed in sip1-i4 cells, although the extent of co-localization of Bgs1 dots with FM4-64 was relatively higher compared with sip1-i4 cells (Figure 9A, 9C, Δapm1). These results suggested that Sip1/AP-1 played a role in the correct sorting of Bgs1 and that Bgs1 was a new cargo of AP-1 dependent trafficking required for correct cell wall synthesis.
Discussion
In this study, we present several lines of evidence that suggest a role for Sip1 in Golgi/endosomal trafficking as an AP-1 accessory protein. Our study identified β-glucan synthase as a new cargo of AP-1-dependent trafficking required for correct cell wall synthesis.
The sip1-i4 mutants displayed phenotypes resembling those associated with Apm1 deletion, including defects in Golgi/endosomal trafficking and secretion, temperature- and immunosuppressant-sensitive growth, and defects in cell integrity. In addition, the sip1-i4 mutation affected AP-1 complex localization at Golgi/endosomes, which suggested a conserved role for Sip1 in AP-1 localization. Together with the physical interaction between Sip1 and the AP-1 complex and the co-localization of these proteins in vivo, these results strongly suggest that Sip1 is an AP-1 accessory protein. Apm1 overexpression suppressed the sip1-i4 mutant phenotypes with regard to membrane trafficking, including abnormal Syb1 localization and defects in vacuole fusion and secretion. Although most of the AP-1 complex was mislocalized in the sip1-i4 mutant cells, overproduction of Apm1 may have increased the amount of the residual AP-1 complex that was localized in the proper organelle, thereby restoring its function. Thus, sip1-i4 mutant phenotypes can be partly attributed to the loss of proper AP-1 complex function due to its mislocalization.
Importantly, our study demonstrated that Sip1 was not essential for endocytosis and that it was an endosomal and not an endocytic protein. A recent study by Jourdain et al. reported that Sip1 was an endocytic vesicle protein that was important for endocytosis [19]. Jourdain et al. assigned Sip1 to endocytic vesicle, since it did not co-localize with a Golgi marker (Anp1), it was only partially localized with a trans-Golgi marker (Sec72), and it co-localized with internalized FM4-64. This pattern could also describe endosomal localization. Our study demonstrated Sip1 endosomal localization based on its co-localization with Apm1 (endosome) and FM4-64 at an early stage of endocytosis.
The sip1-i4 mutation resulted in a termination codon at amino acid position 1434 located within the highly conserved region (HCR), which contains an approximately 200-amino acid segment conserved throughout evolution in this protein family [18]. This mutation resulted in a truncated protein product that lacked 485 amino acids at the C-terminus of the Sip1 protein (corresponding to the last 41 amino acids of the HCR). Studies of budding yeast Laa1 showed that the HCR was dispensable for its interaction with AP-1, but was necessary for the localization of Laa1 to the punctuate structures [18]. Therefore, the Sip1-i4 mutant protein may behave like Laa1ΔHCRp and, thus, supports the importance of HCR in AP-1 localization. This also narrows down the region within the HCR that is important for AP-1 localization. In addition, the effect of the sip1-i4 mutation was more pronounced than the budding yeast Laa1ΔHCRp, as the AP-1 complex appeared to be almost completely mislocalized in cells with the sip1-i4 mutation, even during the early logarithmic phase.
We also showed that both the sip1-i4 and sip1-62 mutants displayed similar phenotypes, including hypersensitivity to temperature, the immunosuppressive drug FK506, valproic acid, and micafungin (Figure 2). In addition, both mutant cells exhibited cytokinesis defect as evidenced by an increased septation index as compared with the wild-type cells and the appearance of multi-septated phenotypes. More importantly, both the mutant alleles showed similar defects in membrane trafficking, including defects in secretion and Golgi/endosomal trafficking as evidenced by the mislocalization of the synaptobrevin Syb1 and the Golgi marker protein Vrg4 (Figure 4). Furthermore, both the mutants did not show defects in the internalization step of endocytosis, although some FM4-64 fluorescent dots were observed in most of the sip1-i4 and sip1-62 mutants (Figure 5). Jourdain et al. reported mislocalization of FM4-64 in the sip1-62 mutants. In normal cells, FM4-64 is delivered to the vacuole. In the mutants even at a permissive temperature FM4-64 is localized at the tips and mid-zone of the cell. Because our data clearly showed transport of Lucifer yellow to the vacuoles in the sip1-62 mutants, we concluded that Sip1 was actually involved in post-endocytic endosomal trafficking toward vacuoles and not in endocytosis. We also observed a genetic interaction between Sip1 and calcineurin. Because the its4-1/sip1-i4 allele showed sensitivity to the calcineurin inhibitor FK506, it may be predicted that Sip1 and calcineurin share an essential function for growth. A possible mechanism of the synthetic lethal interaction between sip1-i4 and calcineurin is cell wall integrity defect. Notably, Bgs1 was localized at Golgi/endosomes in addition to its reported localization at the cell surface and septa, and these localizations were dependent on the Sip1/AP-1 complex. Therefore, the combination of the sip1 mutation and the inhibition of calcineurin by FK506, through mislocalization and the decreased gene expression of Bgs1, may cause severe Bgs1 dysfunction and cell wall defects, which can explain the synthetic lethal interaction. In budding yeast, Valdivia et al. reported such a role for AP-1 in the correct sorting of the chitin synthase Chs6 [39]. However, to our knowledge, there has been no report that a glucan synthase represents a Golgi/endosome localized membrane protein acting as a cargo for the Sip1/AP-1 complex.
We have provided evidence that the Sip1/AP-1 complex maintains the integrity of Golgi/endosomal trafficking, mediates transport of Bgs1. Identifying additional immunosuppressant sensitive mutants may reveal novel players whose functions are important for Golgi/endosomal trafficking.
Supporting Information
Acknowledgments
We would like to thank Dr. T. Toda, Dr. S. Oliferenko, Dr. J. Ishiguro, and the Yeast Resource Centre (YGRC/NBRP; http://yeast.lab.nig.ac.jp/nig) for providing the strains and plasmids. We also would like to express our gratitude to members of the Laboratory of Molecular Pharmacogenomics for their support.
Funding Statement
This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Ohno H (2006) Physiological roles of clathrin adaptor AP complexes: lessons from mutant animals. J Biochem 139: 943–948. [DOI] [PubMed] [Google Scholar]
- 2. Kirchhausen T (1999) Adaptors for clathrin-mediated traffic. Annu Rev Cell Dev Biol 15: 705–732. [DOI] [PubMed] [Google Scholar]
- 3. Robinson MS, Bonifacino JS (2001) Adaptor-related proteins. Curr Opin Cell Biol 13: 444–453. [DOI] [PubMed] [Google Scholar]
- 4. Praefcke GJ, Ford MG, Schmid EM, Olesen LE, Gallop JL, et al. (2004) Evolving nature of the AP2 alpha-appendage hub during clathrin-coated vesicle endocytosis. EMBO J 23: 4371–4383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Slepnev VI, De CP (2000) Accessory factors in clathrin-dependent synaptic vesicle endocytosis. Nat Rev Neurosci 1: 161–172. [DOI] [PubMed] [Google Scholar]
- 6. Page LJ, Sowerby PJ, Lui WW, Robinson MS (1999) γ-synergin: an EH domain-containing protein that interacts with γ-adaptin. J Cell Biol 146: 993–1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Kent HM, McMahon HT, Evans PR, Benmerah A, Owen DJ (2002) γ-adaptin appendage domain: structure and binding site for Eps15 and γ-synergin. Structure 10: 1139–1148. [DOI] [PubMed] [Google Scholar]
- 8. Hirst J, Motley A, Harasaki K, Peak Chew SY, Robinson MS (2003) EpsinR: an ENTH domain-containing protein that interacts with AP-1. Mol Biol Cell 14: 625–641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Lui WW, Collins BM, Hirst J, Motley A, Millar C, et al. (2003) Binding partners for the COOH-terminal appendage domains of the GGAs and gamma-adaptin. Mol Biol Cell 14: 2385–2398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Fazioli F, Minichiello L, Matoskova B, Wong WT, Di Fiore PP (1993) eps15, a novel tyrosine kinase substrate, exhibits transforming activity. Mol Cell Biol 13: 5814–5828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Wong WT, Kraus MH, Carlomagno F, Zelano A, Druck T, et al. (1994) The human eps15 gene, encoding a tyrosine kinase substrate, is conserved in evolution and maps to 1p31-p32. Oncogene 9: 1591–1597. [PubMed] [Google Scholar]
- 12. Chi S, Cao H, Chen J, McNiven MA (2008) Eps15 mediates vesicle trafficking from the trans-Golgi network via an interaction with the clathrin adaptor AP-1. Mol Biol Cell 19: 3564–3575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Mills IG, Praefcke GJ, Vallis Y, Peter BJ, Olesen LE, et al. (2003) EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking. J Cell Biol 160: 213–222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Mattera R, Ritter B, Sidhu SS, McPherson PS, Bonifacino JS (2004) Definition of the consensus motif recognized by γ-adaptin ear domains. J Biol Chem 279: 8018–8028. [DOI] [PubMed] [Google Scholar]
- 15. Hirst J, Borner GH, Harbour M, Robinson MS (2005) The aftiphilin/p200/γ-synergin complex. Mol Biol Cell 16: 2554–2565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Kita A, Sugiura R, Shoji H, He Y, Deng L, et al. (2004) Loss of Apm1, the μ1 subunit of the clathrin-associated adaptor-protein-1 complex, causes distinct phenotypes and synthetic lethality with calcineurin deletion in fission yeast. Mol Biol Cell 15: 2920–2931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Ma Y, Takeuchi M, Sugiura R, Sio SO, Kuno T (2009) Deletion mutants of AP-1 adaptin subunits display distinct phenotypes in fission yeast. Genes Cells 14: 1015–1028. [DOI] [PubMed] [Google Scholar]
- 18. Fernandez GE, Payne GS (2006) Laa1p, a conserved AP-1 accessory protein important for AP-1 localization in yeast. Mol Biol Cell 17: 3304–3317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Jourdain I, Spielewoy N, Thompson J, Dhut S, Yates JR, et al. (2009) Identification of a conserved F-box protein 6 interactor essential for endocytosis and cytokinesis in fission yeast. Biochem J 420: 169–177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Toda T, Dhut S, Superti FG, Gotoh Y, Nishida E, et al. (1996) The fission yeast pmk1 + gene encodes a novel mitogen-activated protein kinase homolog which regulates cell integrity and functions coordinately with the protein kinase C pathway. Mol Cell Biol 16: 6752–6764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Moreno S, Klar A, Nurse P (1991) Molecular genetic analysis of fission yeast Schizosaccharomyces pombe . Methods Enzymol 194: 795–823. [DOI] [PubMed] [Google Scholar]
- 22. Beach D, Piper M, Nurse P (1982) Construction of a Schizosaccharomyces pombe gene bank in a yeast bacterial shuttle vector and its use to isolate genes by complementation. Mol Gen Genet 187: 326–329. [DOI] [PubMed] [Google Scholar]
- 23. Maundrell K (1990) nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine. J Biol Chem 265: 10857–10864. [PubMed] [Google Scholar]
- 24. Bahler J, Wu JQ, Longtine MS, Shah NG, McKenzie A III, et al. (1998) Heterologous modules for efficient and versatile PCR-based gene targeting in Schizosaccharomyces pombe . Yeast 14: 943–951. [DOI] [PubMed] [Google Scholar]
- 25. Novick P, Ferro S, Schekman R (1981) Order of events in the yeast secretory pathway. Cell 25: 461–469. [DOI] [PubMed] [Google Scholar]
- 26. Kaiser CA, Schekman R (1990) Distinct sets of SEC genes govern transport vesicle formation and fusion early in the secretory pathway. Cell 61: 723–733. [DOI] [PubMed] [Google Scholar]
- 27. Cheng H, Sugiura R, Wu W, Fujita M, Lu Y, et al. (2002) Role of the Rab GTP-binding protein Ypt3 in the fission yeast exocytic pathway and its connection to calcineurin function. Mol Biol Cell 13: 2963–2976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Edamatsu M, Toyoshima YY (2003) Fission yeast synaptobrevin is involved in cytokinesis and cell elongation. Biochem Biophys Res Commun 301: 641–645. [DOI] [PubMed] [Google Scholar]
- 29. Dean N, Zhang YB, Poster JB (1997) The VRG4 gene is required for GDP-mannose transport into the lumen of the Golgi in the yeast, Saccharomyces cerevisiae . J Biol Chem 272: 31908–31914. [DOI] [PubMed] [Google Scholar]
- 30. Abe M, Hashimoto H, Yoda K (1999) Molecular characterization of Vig4/Vrg4 GDP-mannose transporter of the yeast Saccharomyces cerevisiae . FEBS Lett 458: 309–312. [DOI] [PubMed] [Google Scholar]
- 31. Abe M, Noda Y, Adachi H, Yoda K (2004) Localization of GDP-mannose transporter in the Golgi requires retrieval to the endoplasmic reticulum depending on its cytoplasmic tail and coatomer. J Cell Sci 117: 5687–5696. [DOI] [PubMed] [Google Scholar]
- 32. Vida TA, Emr SD (1995) A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol 128: 779–792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Riezman H (1985) Endocytosis in yeast: several of the yeast secretory mutants are defective in endocytosis. Cell 40: 1001–1009. [DOI] [PubMed] [Google Scholar]
- 34. Bone N, Millar JB, Toda T, Armstrong J (1998) Regulated vacuole fusion and fission in Schizosaccharomyces pombe: an osmotic response dependent on MAP kinases. Curr Biol 8: 135–144. [DOI] [PubMed] [Google Scholar]
- 35. Ishiguro J, Saitou A, Duran A, Ribas JC (1997) cps1 +, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporin A and papulacandin B. J Bacteriol. 179: 7653–7662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Cortes JC, Konomi M, Martins IM, Munoz J, Moreno MB, et al. (2007) The (1,3)β-D-glucan synthase subunit Bgs1p is responsible for the fission yeast primary septum formation. Mol Microbiol 65: 201–217. [DOI] [PubMed] [Google Scholar]
- 37. Deng L, Sugiura R, Ohta K, Tada K, Suzuki M, et al. (2005) Phosphatidylinositol-4-phosphate 5-kinase regulates fission yeast cell integrity through a phospholipase C-mediated protein kinase C-independent pathway. J Biol Chem 280: 27561–27568. [DOI] [PubMed] [Google Scholar]
- 38. Cortes JC, Ishiguro J, Duran A, Ribas JC (2002) Localization of the (1,3)β-D-glucan synthase catalytic subunit homologue Bgs1p/Cps1p from fission yeast suggests that it is involved in septation, polarized growth, mating, spore wall formation and spore germination. J Cell Sci 115: 4081–4096. [DOI] [PubMed] [Google Scholar]
- 39. Valdivia RH, Baggott D, Chuang JS, Schekman RW (2002) The yeast clathrin adaptor protein complex 1 is required for the efficient retention of a subset of late Golgi membrane proteins. Dev Cell 2: 283–294. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.